Skip to main content
Caplight Logo









Micregen

Micregen

Private
ReadingHealthcare & Life Scienceshttps://micregen.com/

Last Round

VC Round

Apr 1, 2021

Est. Valuation

$124.61M

Total Funding Raised

$1.96M

Company Overview

Micregen is a biotechnology company that develops stem cell-derived secretome therapeutics for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

regenerative medicinesecretome therapeuticscell-free therapybiotechnologydrug discoveryextracellular vesiclestissue repairstem cell researchbiotech startupclinical stage biotechexosome therapyregenerative biotechgmp cell banksneonatal therapeuticsanti-aging medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Micregen Comparables

Compare Micregen with similar companies based on industry and business-model similarity.

Micregen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Secretome Therapeutics
82%
Immunis, Inc.
81%
Noveome Biotherapeutics
81%

Micregen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 1, 2021
SeedApr 1, 2020
SeedFeb 1, 2017
SeedSep 28, 2016

Micregen Investors

Notable investors and investment history

Micregen investors
InvestorRounds
Pitalia CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2024

    Grew 150% QoQ, from 2 to 5 employees.

  • Sep 28, 2016

    $1.43M raised in Seed funding.

Micregen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Micregen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Micregen's valuation, stock price, and market status.

Firmographic Details

HeadquartersReading
Employee Range7
Year Founded2015
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?